Among the antidiabetic medications, synthetic peroxisome proliferator-activated receptor γ (PPARγ) agonists (e.g. thiazolidinediones, TZDs or glitazones) represent the most considerable example of how improving AT function is beneficial for diabetes management. This evidence concerns the gene PPARG and diabetes mellitus.